Evidence map›Paper›PMID 23727623›Full record

ArticleToxicology and applied pharmacology2013

Tissue factor pathway inhibitor prevents airway obstruction, respiratory failure and death due to sulfur mustard analog inhalation.

Raymond C Rancourt, Livia A Veress, Aftab Ahmad, Tara B Hendry-Hofer, Jacqueline S Rioux, Rhonda B Garlick, Carl W White

Abstract read
In one paragraph

Article in Toxicology and applied pharmacology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
5.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 28 citations in OpenAlex.

  1. Countermeasures against Pulmonary Threat Agents.The Journal of pharmacology and experimental therapeutics · 2024
    Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Editor's Highlight: Pulmonary Vascular Thrombosis in Rats Exposed to Inhaled Sulfur Mustard.Toxicological sciences : an official journal of the Society of Toxicology · 2017
    Article
  12. Article
  13. From the Cover: Catalytic Antioxidant Rescue of Inhaled Sulfur Mustard Toxicity.Toxicological sciences : an official journal of the Society of Toxicology · 2016
    Article
  14. Mustard vesicant-induced lung injury: Advances in therapy.Toxicology and applied pharmacology · 2016
    Review
  15. Review
  16. Emerging targets for treating sulfur mustard-induced injuries.Annals of the New York Academy of Sciences · 2016
    Review
  17. Article
  18. Airway tissue plasminogen activator prevents acute mortality due to lethal sulfur mustard inhalation.Toxicological sciences : an official journal of the Society of Toxicology · 2015
    Article
  19. Antifibrinolytic mechanisms in acute airway injury after sulfur mustard analog inhalation.American journal of respiratory cell and molecular biology · 2014
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Raymond C RancourtDepartment of Pediatrics, University of Colorado, Denver, CO, USA. Electronic address: raymond.rancourt@ucdenver.edu.
Livia A Veress
Aftab Ahmad
Tara B Hendry-Hofer
Jacqueline S Rioux
Rhonda B Garlick
Carl W White
University of Colorado Denver · US

Funding

Thiols in sulfur mustard toxicityU54ES015678 · NIEHS · UNIVERSITY OF COLORADO DENVER · PI WHITE, CARL W · 2006 to 2015
$20.5M
NIEHS NIH HHS U54 ES015678
6 · The paper itself

Abstract

unlabelledSulfur mustard (SM) inhalation causes airway injury, with enhanced vascular permeability, coagulation, and airway obstruction. The objective of this study was to determine whether recombinant tissue factor pathway inhibitor (TFPI) could inhibit this pathogenic sequence.

methodsRats were exposed to the SM analog 2-chloroethyl ethyl sulfide (CEES) via nose-only aerosol inhalation. One hour later, TFPI (1.5mg/kg) in vehicle, or vehicle alone, was instilled into the trachea. Arterial O2 saturation was monitored using pulse oximetry. Twelve hours after exposure, animals were euthanized and bronchoalveolar lavage fluid (BALF) and plasma were analyzed for prothrombin, thrombin-antithrombin complex (TAT), active plasminogen activator inhibitor-1 (PAI-1) levels, and fluid fibrinolytic capacity. Lung steady-state PAI-1 mRNA was measured by RT-PCR analysis. Airway-capillary leak was estimated by BALF protein and IgM, and by pleural fluid measurement. In additional animals, airway cast formation was assessed by microdissection and immunohistochemical detection of airway fibrin.

resultsAirway obstruction in the form of fibrin-containing casts was evident in central conducting airways of rats receiving CEES. TFPI decreased cast formation, and limited severe hypoxemia. Findings of reduced prothrombin consumption, and lower TAT complexes in BALF, demonstrated that TFPI acted to limit thrombin activation in airways. TFPI, however, did not appreciably affect CEES-induced airway protein leak, PAI-1 mRNA induction, or inhibition of the fibrinolytic activity present in airway surface liquid.

conclusionsIntratracheal administration of TFPI limits airway obstruction, improves gas exchange, and prevents mortality in rats with sulfur mustard-analog-induced acute lung injury.

Indexed as

Administration, InhalationAirway ObstructionAnimalsBlotting, WesternBronchoalveolar Lavage FluidChemical Warfare AgentsEnzyme-Linked Immunosorbent AssayFibrinFibrinolysisImmunoglobulin MImmunohistochemistryIndicators and ReagentsLipoproteinsMaleMicrodissectionMustard Gas2-chloroethyl ethyl sulfideChemical Warfare AgentsFibrinImmunoglobulin MIndicators and Reagentslipoprotein-associated coagulation inhibitorLipoproteinsMustard GasProteinsProthrombinRecombinant ProteinsTifacoginAirwayCoagulationInhalationLung injurySulfur mustardTFPI

Identifiers

PMID23727623
PMCPMC3775856
OpenAlexW1971339815

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.